No Data
Haizheng Shengcai (688203.SH): has repurchased a total of 0.259% of its shares.
Gelonghui December 2nd, Haizhengshengcai (688203.SH) announced that as of November 30, 2024, the company has repurchased a total of 526,931 shares of the company through the Shanghai Stock Exchange trading system in a centralized bidding trading manner, accounting for 0.259% of the company's total share capital of 202,678,068 shares. The highest price of the repurchase transaction was 10.53 yuan/share, the lowest price was 7.76 yuan/share, and the total amount paid was RMB 4,992,228.97 (excluding stamp duty, transaction commission, and other transaction fees).
Why Zhejiang Hisun BiomaterialsLtd's (SHSE:688203) Shaky Earnings Are Just The Beginning Of Its Problems
Haizheng Raw Materials: Zhejiang Haizheng Biomaterials Co., Ltd. Report for the Third Quarter of 2024
Zhejiang Haizheng Biomaterials Co., Ltd. Report for the Third Quarter of 2024
Hisun Biomaterials Repurchases Shares Under 30 Million Yuan Buyback Scheme
Haizheng Life Sciences (688203.SH): Director Shen Xinghu resigns.
On August 28th, Hai Zheng Sheng Cai (688203.SH) announced that on August 28th, 2024, the board of directors received a written resignation report from Mr. Shen Xinghu, the Chairman of the Company. Due to personal reasons, Mr. Shen Xinghu requested to resign from the seventh board of directors, Chairman of the board of directors, member of the board of directors' audit committee, and convener of the board of directors' strategic committee, and no longer serve as the Company's legal representative. After resigning, Mr. Shen Xinghu will not hold any position in the Company.
Zhejiang Hisun BiomaterialsLtd (SHSE:688203) May Have Issues Allocating Its Capital
No Data
